Lumibird: over 7% growth in quarterly sales
In organic terms, the laser technology specialist claims growth of 3% for its photonics division, driven by a 16% increase in the industrial and scientific segment, and 5.7% for its medical division.
With the gradual lifting of the few obstacles encountered at the end of 2023, and the ramp-up of new defense contracts, the Group claims to be on a strong growth trajectory, and confirms that it is targeting organic growth of at least 8% for 2024.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction